MTOR and hepatocellular carcinoma: We also demonstrated less expression of p-AKT, p-mTOR, and p-4E-BP1 in ChREBP-KO mice compared to WT mice, indicating a ChREBP-associated regulation in AKT/mTOR pathways during HCC development [36].